Monday, July 14, 2025
HomeIndustriesBiotechnology

Biotechnology

Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults

Astellas Pharma Inc. announced that the US Food and Drug Administration (FDA) has placed a clinical hold on the FORTIS Phase 1/2 trial following...

Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...

Molecure to Regain Worldwide Rights to Dual Chitinase Inhibitor OATD-01

Molecure S.A. a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and develop first in class small molecule drug...

Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting

Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, announced that the Company presented new preclinical data demonstrating the...

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...
0FansLike
0FollowersFollow
spot_img

Hot Topics